If you have been reading about bremelanotide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-07-07. Numbers and descriptions here follow the published literature rather than marketing material.
Bremelanotide is a synthetic cyclic heptapeptide developed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and appetite signalling. Its structure contains seven amino acid residues joined by a lactam bridge that closes the ring between two side chains. The molecular formula is C50H68N14O10 and the nominal molecular mass is near 1025 daltons. Much of the early laboratory literature refers to the same molecule by the development code PT-141.
The compound emerged from a research programme examining melanocortin analogues for effects on skin pigmentation. During early human studies, participants reported spontaneous erections as an unexpected side effect, which redirected development toward sexual function rather than tanning. An intranasal formulation was investigated in clinical trials but did not reach market approval. A subcutaneous injectable version later completed the regulatory process, and the nasal route does not appear in approved labelling.
The lactam ring that closes the peptide backbone improves resistance to exopeptidase attack, but the molecule stays susceptible to hydrolysis and oxidation once dissolved. Degradation accelerates with temperature, extreme pH, and light exposure, and repeated freeze-thaw cycles promote aggregation and material loss. Lyophilized powder held desiccated at or below minus twenty degrees Celsius is the common way to keep reference material. Reconstituted solutions are generally kept cold and used within a short window because their stability is far lower than that of the dry solid.
Handling procedures emphasize minimizing moisture uptake, since the dried solid is hygroscopic and can draw water when warmed to room temperature before a vial is opened. Laboratories record lot number, purity, counter-ion content, and residual solvent data supplied by the producer. Impurity profiles are compared run to run, and any shift in retention time or peak shape prompts re-verification against a reference standard. Certificates of analysis are treated as claims to be checked rather than accepted at face value.
Identity and purity testing for this peptide typically relies on reversed-phase high-performance liquid chromatography with ultraviolet detection, reported as area-percent purity. Mass spectrometry, usually in tandem mode, confirms molecular mass and supports quantification in biological matrices. Sequence confirmation may use peptide mapping after enzymatic digestion, while nuclear magnetic resonance and circular dichroism supply supplementary structural detail. No single technique establishes identity alone, so laboratories compare retention time, mass, and fragment pattern against a verified reference standard.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H68N14O10 | Cyclic heptapeptide backbone |
| Molecular mass | Approximately 1025 Da | Nominal mass of the free peptide |
| Appearance | White to off-white lyophilised powder | Typical for purified synthetic peptides |
| Solubility class | Freely soluble in water | Organic solubility is limited |
| Typical storage temperature | −20 °C or below | Protect from moisture and light |
Routine characterisation of bremelanotide relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nm, where the peptide backbone absorbs. Mass spectrometry, typically in tandem mode with electrospray ionisation, confirms identity and supports quantification in biological matrices. Additional checks include amino acid analysis, peptide mapping after enzymatic digestion, and confirmation of the lactam bridge, since incomplete cyclisation produces a mass-shifted by-product. Purity values above 95 percent are common in reference-grade material, though reports vary in how strictly related substances are resolved from the parent peak.
The lyophilised solid is relatively stable when kept dry, protected from light and held at reduced temperature, commonly minus 20 degrees Celsius or lower for long-term storage. In solution the peptide is more vulnerable: tryptophan oxidation, hydrolysis of the lactam bridge and aggregation all become relevant over time, and the rate depends on pH, buffer composition and concentration. Repeated freeze-thaw cycles are generally avoided because they promote aggregation. Aqueous working solutions are typically prepared fresh or split into single-use aliquots to limit degradation before analysis.
Published studies differ in design, population and endpoint definition, so results are not always directly comparable across reports. Some trials used patient-reported measures of desire and distress, while others tracked physiological or behavioural outcomes. Questions that remain open include the durability of effects beyond short follow-up periods, the frequency of transient blood pressure elevation observed after administration, and whether a subtype-selective analogue could separate central effects from pigmentation-related activity. These points are usually framed as unresolved rather than settled in review literature.
PT-141 is the original development code for bremelanotide, a synthetic peptide first studied as a potential tanning and sexual-response agent in the 1990s. Researchers at a small American biotechnology firm designed it as a shortened analogue of melanotan II, which itself came from work on alpha-melanocyte-stimulating hormone. Early screening focused on pigmentation, but behavioural observations in animal models redirected attention toward sexual motivation. That shift made PT-141 one of the first melanocortin compounds investigated specifically for effects on desire rather than on skin colour.
Clinical development proceeded through two routes of administration. An intranasal formulation advanced first, but variable absorption and tolerability problems led to a switch to subcutaneous injection. The United States Food and Drug Administration approved the subcutaneous product in 2019 for hypoactive sexual desire disorder in premenopausal women. Marketing rights subsequently changed hands, and commercial availability has fluctuated since approval. Use in men, in postmenopausal women, and in combination with other agents remains outside the approved label.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
After subcutaneous administration, plasma concentrations rise within roughly thirty minutes and the elimination half-life is short, on the order of two to three hours. Reported physiological responses include transient increases in blood pressure and nausea, which tended to diminish with repeated dosing in trial settings. Because the peptide clears quickly, effects are not expected to persist long after a dose. Absorption from non-injected routes is poorly characterised, and nasal delivery produced variable plasma levels in older work.
Clinical research typically uses randomised, double-blind, placebo-controlled designs. The most common primary endpoint is the desire domain score of the Female Sexual Function Index, sometimes paired with a distress measure. Secondary outcomes include arousal, satisfaction, and event-based counts of satisfying sexual episodes. Across trials, average improvements are modest and individual responses vary widely. Whether benefits persist beyond a few months, and whether they depend on baseline hormone status, remain open questions rather than settled findings.
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
In earlier manuscript versions, the figure is surrounded by numbers and phrases which indicate where in the accompanying treatise a healer might find a particular helpful procedure. For instance, in a German Wound Man now in the Wellcome Library, London (MS 49), the spider crawling up the man's thigh is labelled "Wo eine spynne gesticht, 20" ("When a spider bites, 20"), directing the reader to paragraph 20 of the book for an appropriate cure. Similarly, written along the large spear piercing the figure's left side and penetrating into his stomach is the legend "So der gross viscus wund wirt, 14" ("If the large intestine is injured, 14"). Turning to the corresponding cure number 14, the reader finds:
South Africa manufactured several complete nuclear weapons in the 1980s, but during the 1990s, it became the only country to eliminate its domestically produced nuclear arsenal, and abandon further nuclear weapon production. Nuclear weapons have been detonated on over 2,000 occasions for various testing purposes. Countries have increased their readiness to carry out strategic and tactical nuclear attacks in response to intensifying conflicts, including the Korean War, First and Second Taiwan Strait Crises, Cuban Missile Crisis, Vietnam War, Sino-Soviet border conflict, Yom Kippur War, Gulf War, and Russo-Ukrainian war. The 1962 Cuban Missile Crisis, between the nuclear superpowers of the U.S. and Soviet Union, is often considered the closest call with a nuclear exchange and possible World War III. Additionally, nuclear attack early warning systems have sometimes produced false alarms, increasing the risk of nuclear war, such as Soviet satellites in 1983 and Russian radar in 1995. After the dissolution of the Soviet Union in 1991 and the resultant end of the Cold War, the threat of a major nuclear war between the U.S. and Soviet Union has declined. Concern shifted to the prevention of localized nuclear conflicts resulting from nuclear proliferation, and the threat of nuclear terrorism. However, the threat of nuclear war is considered to have resurged since the start of the current phase of the Russo-Ukrainian war in 2022, particularly with regard to Russian threats to use nuclear weapons during the war.
Edman and Begg's 1967 design involves placing a protein or peptide sample into a spinning cup in a temperature controlled chamber. Reagents are added to cleave the protein one amino acid at the time, followed by solvents to allow extraction of reagents and byproducts. A series of analysis cycles is performed to identify a sequence, one cycle for each amino acid, and the cycle times were lengthy. Hood and Hunkapiller made a number of modifications, further automating steps in the analysis and improving effectiveness and shortening cycle time. By applying reagents in the gas phase instead of the liquid phase, the retention of the sample during the analysis and the sensitivity of the instrument were increased. Polybrene was used as a substrate coating to better anchor proteins and peptides, and the purification of reagents was improved. HPLC analysis techniques were used to reduce analysis times and extend the technique's applicable range. The amount of protein required for an analysis decreased, from 10-100 nanomoles for Edman and Begg's protein sequencer, to the low picomole range, a revolutionary increase in the sensitivity of the technology. The new sequencer offered significant advantages in speed and sample size compared to commercial sequencers of the time, the most popular of which were built by Beckman Instruments.
== Structure and basic properties == The N−C−C geometry is linear in nitriles, reflecting the sp hybridization of the triply bonded carbon. The C−N distance is short at 1.16 Å, consistent with a triple bond. Nitriles are polar, as indicated by high dipole moments. As liquids, they have high relative permittivities, often in the 30s.
Sources: en.wikipedia.org
In 1978 he had established a Women's Military Academy in Tripoli, encouraging all women to enlist for training. The measure was hugely controversial and voted down by the GPC in February 1983. Gaddafi remained adamant, and when it was again voted down by the GPC in March 1984, he refused to abide by the decision, declaring that "he who opposes the training and emancipation of women is an agent of imperialism, whether he likes it or not." The Jamahiriya's radical direction earned the government many enemies. Most internal opposition came from Islamic fundamentalists, inspired by the events of the 1979 Iranian Revolution. In February 1978, Gaddafi discovered that his head of military intelligence was plotting to kill him and increasingly entrusted security to his Qadhadfa tribe. Many who had seen their wealth confiscated turned against the administration, and Western-funded opposition groups were founded by exiles. Most prominent was the National Front for the Salvation of Libya (NFSL), which orchestrated militant attacks against Libya's government. Another, al-Borkan, began killing Libyan diplomats abroad. Following Gaddafi's command to kill these "stray dogs", the Revolutionary Committees set up overseas branches to suppress counter-revolutionary activity, assassinating dissidents. Although Syria and Israel also employed hit squads, Gaddafi was unusual in publicly bragging about his use of them; in April 1980, he ordered all dissidents to return home by 10 June or be "liquidated wherever you are".
==== Lipofection ==== In lipofection, the gene is injected with the help of liposomes. The DNA sequence is encapsulated in a liposome with the same composition as the cell membrane. This method allows it to directly fuse with the membrane, or be endocytosed, which then releases the DNA into the cell. Lipofection is often used because it works with many different cell types, is highly reproducible, and is a fast method for both stable and transient expression.
===== Oceania ===== New Zealand - DMT is classified as a Class A drug under the Misuse of Drugs Act 1975. Australia - DMT is listed as a Schedule 9 prohibited substance in Australia under the Poisons Standard (October 2015). A Schedule 9 drug is outlined in the Poisons Act 1964 as "Substances which may be abused or misused, the manufacture, possession, sale, or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of the CEO". Between 2011 and 2012, the Australian federal government was considering changes to the Australian Criminal Code that would classify any plants containing any amount of DMT as "controlled plants". DMT itself was already controlled under current laws. The proposed changes included other similar blanket bans for other substances, such as a ban on any and all plants containing mescaline or ephedrine. The proposal was not pursued after political embarrassment on realisation that this would make the official floral emblem of Australia, Acacia pycnantha (golden wattle), illegal. The Therapeutic Goods Administration and federal authority had considered a motion to ban the same, but this was withdrawn in May 2012 (as DMT may still hold potential entheogenic value to native and/or religious people). Under the Misuse of Drugs Act 1981 6.0g (3/16oz) of DMT is considered enough to determine a court of trial and 2.0g (1/16oz) is considered intent to sell and supply. In December 2004, the U.S.
Sources: en.wikipedia.org
McCoy warned that, if China's numerous breaches on Taiwan become "a crippling embargo of Taiwan", the US would lose Taiwan, risking a break of "America's island chain in the Pacific littoral, pushing it back to a 'second island chain' in the mid-Pacific", regardless of the US's decisions on Taiwan. He further cited growing anti-American sentiment in the Philippines, the opposition toward AUKUS (trilateral security partnership between Australia, the United Kingdom, and the United States) from certain members of the Labor Party as a threat to Australia's sovereignty, and the Republican Party populism in the US under Trump (or his successor-in-line JD Vance) potentially curtailing the US's ability to maintain its alliance with the Asia-Pacific countries. In January 2025, almost two weeks before Biden ended his term, Hoover Institution senior fellow Niall Ferguson wrote that the US has had "a second cold war" with China for at least six years and that the war further intensified under the Biden administration. Ferguson drew comparisons between Trump and then-US president Ronald Reagan, like assassination attempts on them, but further suggested that Trump use the Reagan administration's past approach in foreign policy.
Emboldened by the footage, Aditya gets reinstated by the police by proving his physical and mental stability. He then traces Ajay's true biological origins to Hari. Attempting to evade Aditya, Hari organises the murders of numerous police officers. Undeterred, Aditya traces Hari's location to an old office building of Mumbai Media that media tycoon Pramod Gupta owns, who is one of Hari's associates. With the help of the police, Aditya launches a raid on the complex. He kills Hari's goons and captures Gupta but fails to capture Hari, who retreats to the site of his earlier massacre and lures Aditya by holding the families of the murdered police officers hostage at gunpoint. Aditya fights with Hari and wins. Hari attempts to shoot Aditya, but he throws a knife at Hari's neck then stabs him repeatedly to death. As Aditya walks out of the police station, a young boy dressed in a police uniform looks at him and salutes with a smile. Aditya returns the smile and salute.
== Signs and symptoms == In one of the few reported cases, the subject presented with muscle weakness and fatigue, muscle twitching, excessive sweating and salivation, small joint pain, itching and weight loss. The subject also developed confusional episodes with spatial and temporal disorientation, visual and auditory hallucinations, complex behavior during sleep and progressive nocturnal insomnia associated with diurnal drowsiness. There was also severe constipation, urinary incontinence, and excessive lacrimation. When left alone, the subject would slowly lapse into a stuporous state with dreamlike episodes characterized by complex and quasi-purposeful gestures and movements (enacted dreams). Marked hyperhidrosis and excessive salivation were evident. Neurological examination disclosed diffuse muscle twitching and spontaneous and reflex myoclonus, slight muscle atrophy in the limbs, absence of tendon reflexes in the lower limbs and diffuse erythema especially on the trunk with scratching lesions of the skin. Compulsive behaviours, stereotypies and reduplicative paramnesias can be part of the CNS spectrum.
Sources: en.wikipedia.org
It is a synthetic cyclic peptide that acts as an agonist at melanocortin receptors. It is not a hormone replacement therapy and not a vasodilator in the usual clinical sense, although it does affect vascular tone. Chemically it belongs to the melanocortin analogue family.
PT-141 was the internal development code used during early research and it persists in older publications, conference abstracts, and informal listings. The code and the approved name refer to the same molecule. Its continued use reflects habit in the literature rather than any difference in substance.
No. The intranasal form was studied in trials but was never approved, and absorption through the nasal route varies considerably between individuals. Approved labelling covers a subcutaneous injection only. Any nasal product sold outside regulated channels falls outside verified manufacturing.
Chemical degradation such as hydrolysis and oxidation proceeds more slowly as temperature falls. Cold storage also limits microbial growth in reconstituted material. Repeated warming should be avoided because thermal cycling stresses the peptide.